Blockade of IL10 signaling promotes TLR9-driven liver dysfunction by allowing T cell receptor-mediated T cell activation
Year: 2026
Type: article
Abstract: Objective Deficient IL10 signaling can contribute to macrophage activation syndrome (MAS). TLR-9 drives innate immune activation and has been used to model MAS. IL10 promotes T cell tolerance and the development of T regulatory cells. We hypothesized that in TLR-9-mediated innate immune activation, blocking IL10 would increase T cell activation and worsen MAS-associated organ dysfunction. Methods C57BL/6 mice (n=3-11/cohort) were injected with A) CpG ODN1826, a TLR9 agonist, 50μg every other day for 5 doses on days -8 — 0 (CpGLo), B) CpG 500μg on Day 0 (CpGHi), or C) CpGHi+αIL10-R blocking antibody. OTI and OTII mice, which respectively contain CD8 and CD4 cells with transgenic T cell receptors, do not respond to antigens. Wild-type C57Bl/6, OTI, and OTII mice received CpGHi+αIL10-R. Baseline (untreated) mice were included in each experiment. Animals were sacrificed one day post-challenge. Results The CpGHi cohort had lower WBC ( p< 0.0001), higher ferritin ( p = 0.0035) and higher ALT ( p< 0.05) and lower bile acid transporter mRNA levels ( p < 0.05). The CpGHi cohort had increased percentages of B cells expressing activation markers (CD80, CD86, and MHC-I, p< 0.05), of dendritic cells expressing CD86 ( p= 0.03), and of CD4 ( p< 0.0001) and CD8 ( p= 0.025) T cells expressing CD69. Compared to CpGHi, CpGHi+αIL10-R treatment increased Nur77 expression on CD4 and CD8 T cells ( p< 0.0001), did not alter innate immune cells, and was associated with worse liver function ( p< 0.05). We noted significant expansion of Nur77 + CD69 + CD8 T cells in OTI and OTII mice, indicating a TCR-associated activation leading to a CD8 T cell response. Conclusions In TLR9-induced hyperinflammation, IL10 restrained a feedforward loop of innate and T cell activation. The specificity of the innate and T cell interaction is unclear and may represent an autoimmune activation of CD8 T cells.
Source: Frontiers in Immunology
Authors: Grace Fisler(Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing), Matthew Eremita(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – review & editing), Shivani Chhabra(Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – review & editing), Mariana R. Brewer(Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – review & editing), Mei Qi(Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing), Corina N. Nava(Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing), Saloni Dewan(Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing), Mabel N. Abraham(Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – review & editing), Joyce Hui Yuen, Clifford S. Deutschman(Data curation, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing), Matthew D. Taylor(Formal analysis, Methodology, Software, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Northwell Health, Feinstein Institute for Medical Research
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7172535040
